Company Filing History:
Years Active: 2020
Title: Mads Kreilgaard: Innovator in Pharmaceutical Formulations
Introduction
Mads Kreilgaard is a notable inventor based in Farum, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the management of movement disorders. His innovative approach combines various active ingredients to enhance treatment efficacy.
Latest Patents
Mads Kreilgaard holds a patent for an orally available pharmaceutical formulation suitable for improved management of movement disorders. The invention provides a pharmaceutical formulation for oral administration that includes an agonist of two or more of the 5-HT1B, 5-HT1D, and 5-HT1F receptors, such as zolmitriptan, combined with a 5-HT1A-R agonist like buspirone. This special formulation is designed to achieve synergy from both active ingredients while allowing for ease of administration and reducing the risk of adverse effects.
Career Highlights
Mads Kreilgaard is associated with Contera Pharma Aps, where he continues to develop innovative pharmaceutical solutions. His work focuses on creating formulations that improve patient outcomes in the treatment of movement disorders. With 1 patent to his name, he has established himself as a key player in the pharmaceutical industry.
Collaborations
Mads collaborates with talented professionals in his field, including John Bondo Hansen and Mikael S Thomsen. Their combined expertise contributes to the advancement of pharmaceutical innovations.
Conclusion
Mads Kreilgaard's contributions to pharmaceutical formulations demonstrate his commitment to improving treatment options for movement disorders. His innovative work continues to pave the way for advancements in the field.